Missouri City, TX, United States of America

Hong Zhao

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: The Methodist Hospital. Active years: 2019-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hong Zhao. Retrieved from https://idiyas.com/inventor/hong-zhao-ym64omam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2019-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Inventor Hong Zhao

Introduction

Hong Zhao is a notable inventor based in Missouri City, TX (US). He has made significant contributions to the field of medical treatments, particularly in oncology. With a total of 2 patents, his work focuses on innovative methods for treating various tumors and enhancing cancer therapies.

Latest Patents

One of Hong Zhao's latest patents is titled "Compositions and methods for treating Ewing family tumors." This patent describes a method for treating a sarcoma by administering a tyrosine kinase inhibitor and a biguanide compound. It also outlines a process for obtaining a tumor sample and determining gene expression levels of specific genes before administering the treatment. Additionally, a pharmaceutical composition for treating Ewing family tumors is disclosed, which includes a tyrosine kinase inhibitor, a biguanide compound, and a pharmaceutically acceptable excipient.

Another significant patent is "Compositions and methods for selectively inhibiting intestinal carboxylesterase 2 enzyme activity." This invention provides a method for treating diarrhea induced by chemotherapy agents through the administration of a carboxylesterase 2 (CES2) inhibitor, such as hesperetin, naringenin, or 2',4'-dihydroxychalcone. It also includes a method for treating cancer by combining a chemotherapy agent with these inhibitors, along with a composition that contains both a chemotherapy agent and the aforementioned compounds.

Career Highlights

Hong Zhao is currently associated with The Methodist Hospital, where he continues to advance his research and innovations in cancer treatment. His work has the potential to significantly impact the lives of patients suffering from various forms of cancer.

Collaborations

He has collaborated with esteemed colleagues, including Stephen T C Wong and Ren Kong, to further enhance the scope and effectiveness of his research.

Conclusion

In summary, Hong Zhao is a dedicated inventor whose innovative patents contribute to the advancement of cancer treatment methodologies. His work exemplifies the importance of research and innovation in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…